A multinational pharmaceutical company with broad manufacturing capabilities was considering horizontally expanding their portfolio to include biosimilars.  Kineticos was charged with providing a detailed analysis of the market opportunity for two unique biosimilar licensing opportunities, as well as any gaps with respect to resource requirements that such an expansion would necessitate.

NOTE: Use your cursor or the tool-bar located at the bottom to review all available pages, including example deliverables.


To download the full case study including example deliverables, click here:  In-Licensing

Subscribe to the Kineticos Research Institute to receive weekly emails containing insightful content.

Back to Corporate Development